Thomas Honger Callisen

Title: Thomas Honger Callisen: Innovator in Lipase Variants and Granule Stabilization

Introduction

Thomas Honger Callisen is a notable inventor based in Frederiksberg C, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of lipase variants and granule stabilization technologies. With a total of 3 patents to his name, Callisen's work has had a meaningful impact on various applications in the industry.

Latest Patents

One of Callisen's latest patents focuses on lipase variants. This invention provides variant lipases that exhibit a reduced tendency to generate odors, achieved by introducing mutations in specific regions identified in a parent lipase. Another significant patent relates to the stabilization of granules. This invention describes granules that comprise a core matrix and one or more coatings. The core matrix includes an active compound, a synthetic polymer in an amount ranging from 0.1 to 10% by weight of the matrix, and one or more antioxidants and/or reducing agents, where the amount is between 0.2 to 5% by weight of the matrix.

Career Highlights

Throughout his career, Thomas Honger Callisen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His expertise in enzyme technology and formulation has positioned him as a valuable asset in these organizations.

Collaborations

Callisen has collaborated with notable colleagues such as Jesper Vind and Allan Svendsen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Thomas Honger Callisen is a distinguished inventor whose work in lipase variants and granule stabilization continues to influence the biotechnology industry. His innovative contributions and collaborations highlight his commitment to advancing scientific knowledge and practical applications.